Publication in Vaccines Highlights Important Benefits of PharmaJet® Tropis® Intradermal Vaccination over Intramuscular Standard of Care

Publication in Vaccines Highlights Important Benefits of PharmaJet® Tropis® Intradermal Vaccination over Intramuscular Standard of Care

GOLDEN, Colo.--(BUSINESS WIRE)--Jun 5, 2025-

Vaccines publishes key benefits of PharmaJet Tropis ID vaccine over IM SoC - BioTuesdays

Closely held PharmaJet announced that the results of an implementation research study—titled Evaluating the impact of needle-free delivery of inactivated polio vaccine on Nigeria’s routine immunization program: An implementation hybrid trial—have been published in the top-tier journal Vaccines. The study highlights significant benefits of the Tropis intradermal (ID) vaccine compared to the intramuscular (IM) standard of care (SoC). According to …